Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

WHO-EORTC classification for cutaneous lymphomas.

Rein Willemze1, Elaine S Jaffe, Günter Burg

  • 1Department of Dermatology, B1-Q-93, Leiden University Center, PO Box 9600, 2300 RC Leiden, The Netherlands. rein.willemze@planet.nl

Blood
|February 5, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triage Performance of FAM19A4/miR124-2 Methylation: 18-Month Follow-Up Results From a Prospective Observational Study Within the Dutch Primary HPV-Based Cervical Screening Program.

International journal of cancer·2026
Same author

Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-β7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab.

Clinical & translational immunology·2026
Same author

Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.

Communications medicine·2026
Same author

Molecular Insights Into the Natural History of Anal HSIL.

Journal of medical virology·2025
Same author

Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial.

International journal of cancer·2024
Same author

Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in Germany.

BMC infectious diseases·2024
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles
This summary is machine-generated.

The new WHO-EORTC classification unifies previous systems for primary cutaneous lymphomas, addressing debates in classifying cutaneous T-cell and B-cell lymphomas. This revised system offers clearer diagnostic criteria and clinical significance for skin lymphoma diagnosis.

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Existing European Organization for Research and Treatment of Cancer (EORTC) and World Health Organization (WHO) classifications for primary cutaneous lymphomas have limitations.
  • Discrepancies in classifying cutaneous T-cell lymphomas (excluding mycosis fungoides and Sezary syndrome) and primary cutaneous CD30+ lymphoproliferative disorders, along with terminology for cutaneous B-cell lymphomas, caused confusion.

Purpose of the Study:

  • To introduce and describe the newly established WHO-EORTC classification for primary cutaneous lymphomas.
  • To highlight the characteristic features of various primary cutaneous lymphomas and related skin neoplasms.
  • To compare the new classification with previous systems and present clinical significance data.

Main Methods:

  • Consensus meetings between EORTC and WHO classification representatives.

Related Experiment Videos

  • Description of characteristic features of primary cutaneous lymphomas and other hematologic neoplasms.
  • Analysis of relative frequency and survival data from 1905 patients in Dutch and Austrian registries.

    • Main Results:

    • Agreement reached on a unified WHO-EORTC classification system.
    • Detailed description of distinct primary cutaneous lymphoma entities and their features.
    • Presentation of epidemiological and survival data supporting the clinical relevance of the new classification.

    Conclusions:

    • The WHO-EORTC classification provides a standardized approach to diagnosing primary cutaneous lymphomas.
    • This unified system resolves previous ambiguities in lymphoma classification.
    • The presented data underscore the clinical utility and significance of the new classification in patient management.